DSP Gene Epidermolysis bullosa lethal acantholytic Genetic Test
Components: DSP Gene Epidermolysis bullosa lethal acantholytic Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for DSP Gene Epidermolysis bullosa, lethal acantholytic NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DSP Gene Epidermolysis bullosa, lethal acantholytic NGS Genetic DNA Test gene DSP
Test Details
DSP Gene Epidermolysis bullosa is a genetic disorder characterized by the presence of mutations in the DSP gene. This gene provides instructions for producing the desmoplakin protein, which plays a crucial role in maintaining the structure and integrity of the skin. Epidermolysis bullosa refers to a group of rare genetic conditions that cause the skin to be extremely fragile and prone to blistering and tearing. Lethal acantholytic epidermolysis bullosa is a severe form of the disorder that is usually fatal shortly after birth.
NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of DSP Gene Epidermolysis bullosa, NGS Genetic Test can be used to identify mutations or variations in the DSP gene that may be responsible for the condition. By identifying specific genetic mutations, NGS Genetic Test can help in diagnosing DSP Gene Epidermolysis bullosa, confirming the presence of the disorder, and providing information about its severity and potential complications. This information can be crucial for determining appropriate treatment strategies and providing genetic counseling to affected individuals and their families.
Test Name | DSP Gene Epidermolysis bullosa lethal acantholytic Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for DSP Gene Epidermolysis bullosa, lethal acantholytic NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DSP Gene Epidermolysis bullosa, lethal acantholytic NGS Genetic DNA Test gene DSP |
Test Details |
DSP Gene Epidermolysis bullosa is a genetic disorder characterized by the presence of mutations in the DSP gene. This gene provides instructions for producing the desmoplakin protein, which plays a crucial role in maintaining the structure and integrity of the skin. Epidermolysis bullosa refers to a group of rare genetic conditions that cause the skin to be extremely fragile and prone to blistering and tearing. Lethal acantholytic epidermolysis bullosa is a severe form of the disorder that is usually fatal shortly after birth. NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of DSP Gene Epidermolysis bullosa, NGS Genetic Test can be used to identify mutations or variations in the DSP gene that may be responsible for the condition. By identifying specific genetic mutations, NGS Genetic Test can help in diagnosing DSP Gene Epidermolysis bullosa, confirming the presence of the disorder, and providing information about its severity and potential complications. This information can be crucial for determining appropriate treatment strategies and providing genetic counseling to affected individuals and their families. |